Doxycycline Appropriateness Assessment
Doxycycline is appropriate for specific, evidence-based indications including bacterial STI post-exposure prophylaxis in MSM and transgender women at high risk, treatment of chlamydia, alternative treatment for syphilis, and various other bacterial infections—but requires careful patient selection, proper dosing, and monitoring for side effects.
Key Clinical Decision Points
For STI Post-Exposure Prophylaxis (Doxy PEP)
Doxy PEP is specifically recommended for men who have sex with men (MSM) and transgender women who have had a bacterial STI (syphilis, chlamydia, or gonorrhea) diagnosed in the past 12 months 1. This represents a strong recommendation based on three large randomized controlled trials demonstrating significant reductions in bacterial STI acquisition 1.
Dosing and administration:
- 200 mg taken within 72 hours after oral, vaginal, or anal sex
- Maximum 200 mg per 24-hour period
- Take as soon as possible after exposure for optimal efficacy 1
Required Baseline and Follow-up Protocol
Before initiating doxy PEP 1:
- Screen for gonorrhea and chlamydia at all anatomic sites of exposure (pharyngeal, rectal, urethral)
- Obtain serologic testing for syphilis
- Screen for HIV per CDC guidelines
- Review complete medication list for drug interactions
Ongoing monitoring every 3-6 months:
- Repeat STI screening at anatomic sites of exposure
- HIV screening for HIV-negative patients
- Assess for side effects
- Re-evaluate continued need for prophylaxis 1
Critical Safety Considerations
Side Effects to Counsel Patients About
The most common adverse effects include 1:
- Photosensitivity (advise sun protection and avoidance of excessive UV exposure)
- Esophagitis and esophageal ulceration (take with full glass of water, remain upright for 1 hour after dosing)
- Gastrointestinal symptoms (nausea, vomiting, diarrhea—take with food to minimize)
- Potential antimicrobial resistance development in other pathogens
- Unknown long-term effects on microbiome
Drug Interactions Requiring Attention
Separate doxycycline by at least 2 hours from 1:
- Dairy products
- Antacids
- Calcium, iron, magnesium, or sodium bicarbonate supplements
Important interactions 2:
- May decrease effectiveness of oral contraceptives
- Anticoagulants may require dose adjustment (decreased prothrombin activity)
- Avoid concurrent use with penicillin (bacteriostatic vs bactericidal interference)
- Barbiturates, carbamazepine, phenytoin decrease doxycycline half-life
No clinically relevant interactions with gender-affirming hormonal therapy 1.
FDA-Approved Treatment Indications
Beyond STI prophylaxis, doxycycline is FDA-approved for 2:
- Chlamydia trachomatis infections (urethral, endocervical, rectal)
- Nongonococcal urethritis
- Lymphogranuloma venereum
- Respiratory infections (Mycoplasma pneumoniae, H. influenzae)
- Rickettsial infections
- Alternative for syphilis when penicillin contraindicated
- Malaria prophylaxis (short-term <4 months)
- Anthrax post-exposure prophylaxis
Common Pitfalls to Avoid
Do not prescribe doxy PEP outside recommended populations (MSM and transgender women with recent bacterial STI history)—evidence does not support use in cisgender women or low-risk populations 1
Do not exceed 200 mg per 24 hours—this is a hard maximum regardless of number of sexual encounters 1
Do not skip baseline STI screening—treating undiagnosed infections is critical before starting prophylaxis 1
Do not prescribe without establishing follow-up plan—ongoing monitoring every 3-6 months is mandatory, not optional 1
Do not use as gonorrhea treatment—while doxycycline shows activity against some N. gonorrhoeae strains, elevated antimicrobial resistance makes it inappropriate as primary gonorrhea therapy 1, 2
Contraindications and Cautions
Absolute contraindications 2:
- Pregnancy (tetracyclines cause fetal harm)
- Children under 8 years (permanent tooth discoloration)
Use with caution and enhanced monitoring:
- Patients with esophageal disorders
- Renal insufficiency (though doxycycline does not accumulate like other tetracyclines)
- History of intracranial hypertension
- Concurrent anticoagulation therapy
Implementation as Part of Comprehensive Sexual Health
Doxy PEP must be embedded within a broader prevention strategy 1:
- Risk reduction counseling (condom use, partner reduction)
- Linkage to HIV PrEP for HIV-negative patients
- Linkage to HIV care for people living with HIV
- Recommended vaccinations (HPV, hepatitis A/B, mpox as indicated)
- Regular STI screening regardless of symptoms
The prescription should be patient-managed, allowing individuals to self-administer after sexual exposure based on shared decision-making about their sexual behavior patterns 1.